HHS tags $727M for community health centers

The U.S. Department of Health and Human Services has awarded $727 million to 143 community health centers across the country to address pressing construction and renovation needs and expand access to quality healthcare. The funds are the first in a series of awards that will be made available to community health centers under the Patient Protection and Affordable Care Act (PPACA).

Community health centers deliver preventive and primary care services to nearly 19 million patients, about 40 percent of whom have no health insurance. More than 7,900 service delivery sites around the U.S. provide care to patients regardless of their ability to pay; charges for services are set according to income, according to HHS.

The Capital Development program grants, administered by HHS’ Health Resources and Services Administration (HRSA), build on the more than $2 billion investment in community health centers in the American Recovery and Reinvestment Act (ARRA). A state-by-state list of ARRA investments in community health centers is available here

During the next five years, the PPACA provides $11 billion in funding for the operation, expansion and construction of community health centers across the country. This expansion of sites and services will help community health centers to serve nearly double the number of patients receiving care, regardless of their insurance status.

For more information on HRSA’s community health center program, click here

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.